Smith Justin S, Ogden Alfred T, Shafizadeh Stephen, Fessler Richard G
Department of Neurological Surgery, University of Virginia, Charlottesville, VA 22908, USA.
J Spinal Disord Tech. 2010 Feb;23(1):30-4. doi: 10.1097/BSD.0b013e318193c16c.
Retrospective review of consecutive case series.
To assess the safety and efficacy of the microendoscopic approach for treatment of recurrent lumbar disc herniation.
The standard surgical approach for the treatment of recurrent disc herniation uses an open technique with a wide exposure. Many would consider a minimally invasive approach such as microendoscopic discectomy (MED) to be contraindicated in the setting of recurrent disc herniation.
Sixteen consecutive patients with recurrent lumbar disc herniation who failed conservative management underwent MED. Before surgery and at follow-up, patients completed the Oswestry Disability Index, SF-36, and assessment of leg pain using the Visual Analog Scale. Outcome was also assessed using modified McNab criteria.
No case required conversion to an open procedure. Mean operative time was 108 minutes, and mean estimated blood loss was 32 mL. The only surgical complications were 2 durotomies that were treated with dural sealant without sequelae. Mean hospital stay was 23 hours, and mean follow-up was 14.7 months. Approximately 80% of patients had good or excellent outcomes based on modified McNab criteria. The remaining 3 patients had fair outcomes, and no patient had a poor outcome. All standardized measures improved significantly, including mean Visual Analog Scale for leg pain (8.2 to 2.2, P<0.001), mean Oswestry Disability Index (59.3 to 26.7, P<0.001), SF-36 Physical Component Summary score (28.3 to 42.4, P<0.001), and SF-36 Mental Component Summary score (38.2 to 48.3, P<0.001). As of last follow-up no patient has showed recurrence of herniation or evidence of delayed instability.
MED is a safe and effective surgical approach for the treatment of recurrent lumbar disc herniation. Standardized measures of outcome show that MED for recurrent herniation produces improvement in pain, disability, and functional health that is at least comparable with outcomes reported for conventional open microdiscectomy.
对连续病例系列进行回顾性研究。
评估显微内镜手术治疗复发性腰椎间盘突出症的安全性和有效性。
治疗复发性椎间盘突出症的标准手术方法采用广泛暴露的开放技术。许多人认为在复发性椎间盘突出症的情况下,诸如显微内镜下椎间盘切除术(MED)之类的微创方法是禁忌的。
16例经保守治疗无效的复发性腰椎间盘突出症患者接受了MED手术。手术前及随访时,患者完成Oswestry功能障碍指数、SF-36量表,并使用视觉模拟量表评估腿痛情况。还采用改良的McNab标准评估结果。
无病例需要转为开放手术。平均手术时间为108分钟,平均估计失血量为32毫升。仅有的手术并发症是2例硬脊膜切开,使用硬脊膜封闭剂治疗后无后遗症。平均住院时间为23小时,平均随访时间为14.7个月。根据改良的McNab标准,约80%的患者预后良好或极佳。其余3例患者预后一般,无患者预后差。所有标准化测量指标均有显著改善,包括腿痛视觉模拟量表平均分(从8.2降至2.2,P<0.001)、Oswestry功能障碍指数平均分(从59.3降至26.7,P<0.001)、SF-36生理健康评分(从28.3升至42.4,P<0.001)以及SF-36心理健康评分(从38.2升至48.3,P<0.001)。截至最后一次随访,无患者出现椎间盘突出复发或延迟性不稳定的迹象。
MED是治疗复发性腰椎间盘突出症的一种安全有效的手术方法。标准化的结果测量表明,MED治疗复发性椎间盘突出症在疼痛、功能障碍和功能健康方面的改善至少与传统开放式显微椎间盘切除术的报告结果相当。